Immunological reagents and uses therefor

US10011602B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10011602-B2
Application numberUS-201314413164-A
CountryUS
Kind codeB2
Filing dateJul 5, 2013
Priority dateJul 6, 2012
Publication dateJul 3, 2018
Grant dateJul 3, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides a ligand which binds to MR1 wherein said binding results in binding of the MR1 to MAIT cells.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of detecting the presence of MAIT cells in a biological sample from a subject, the method comprising the steps of a) contacting the biological sample with antigen presenting cells expressing MR1 bound to a ligand or a soluble form of MR1 bound to a ligand, under conditions that would allow binding of the MR1 or the soluble form of MR1 with MATT cells present in the sample, wherein the ligand is a compound selected from the group consisting of rRL-6HM, rRL-6AM, RL-6M, RP-5PA, 6-formyl pterin, acetyl 6-formyl pterin, 6-methyl-7-hydroxy-8-ribityl lumazine, and 6-,7-dimethyl-8-Ribityl Lumazine; and b) detecting the presence of MAIT cell bound MR1 or MAIT cell bound soluble form of MR1 in the biological sample, thereby detecting the presence of MAIT cells in a biological sample from a subject. 2. The method according to claim 1 , wherein the ligand is rRL-6HM. 3. The method of claim 1 , wherein the biological sample is a biological fluid. 4. The method of claim 1 , wherein the biological sample is a cell sample. 5. The method of claim 1 , wherein the biological sample is a tissue sample. 6. The method of claim 3 , wherein the biological fluid is serum, lymph, or blood. 7. The method of claim 5 , wherein the tissue sample is a bone marrow or a tissue biopsy sample including mucosal tissue. 8. The method of claim 7 , wherein the tissue biopsy sample is from the gut, gut lamina propria, or lungs. 9. The method of claim 1 , wherein the MR1 is a human, primate, or mouse MR1 polypeptide. 10. The method of claim 8 , wherein the MR1 polypeptide comprises SEQ ID NO: 1 or SEQ ID NO: 4. 11. The method of claim 1 , wherein the subject is a human.

Assignees

Inventors

Classifications

  • MHC-molecules, e.g. HLA-molecules · CPC title

  • C07D475/04Primary

    with a nitrogen atom directly attached in position 2 · CPC title

  • White blood cells · CPC title

  • with an oxygen atom directly attached in position 4 · CPC title

  • MHC-molecules, e.g. HLA-molecules · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10011602B2 cover?
The present invention provides a ligand which binds to MR1 wherein said binding results in binding of the MR1 to MAIT cells.
Who is the assignee on this patent?
Univ Melbourne, Univ Monash, Univ Queensland
What technology area does this patent fall under?
Primary CPC classification C07D475/04. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jul 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).